ATE114471T1 - Verfahren zur behandlung und vorbeugung des verlustes von knochenmasse. - Google Patents

Verfahren zur behandlung und vorbeugung des verlustes von knochenmasse.

Info

Publication number: ATE114471T1
Authority: AT; Austria
Prior art keywords: vitamin; treatment; alpha; bone mass; active
Prior art date: 1988-08-02

Application number

AT89910341T

Other languages

English (en)

Inventor

Hector F Deluca

Charles W Bishop

Richard B Mazess

John C Gallagher

Original Assignee

Bone Care Int Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-08-02

Filing date

1989-08-02

Publication date

1994-12-15

1989-08-02 Application filed by Bone Care Int Inc filed Critical Bone Care Int Inc

1994-12-15 Application granted granted Critical

1994-12-15 Publication of ATE114471T1 publication Critical patent/ATE114471T1/de

Links

210000000988 bone and bone Anatomy 0.000 title abstract 3
230000002265 prevention Effects 0.000 title 1
229930194270 alpha-Vitamin Natural products 0.000 abstract 3
229960002061 ergocalciferol Drugs 0.000 abstract 2
230000004936 stimulating effect Effects 0.000 abstract 2
239000011653 vitamin D2 Substances 0.000 abstract 2
QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical class C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 abstract 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
208000037147 Hypercalcaemia Diseases 0.000 abstract 1
206010020590 Hypercalciuria Diseases 0.000 abstract 1
208000001132 Osteoporosis Diseases 0.000 abstract 1
230000009102 absorption Effects 0.000 abstract 1
238000010521 absorption reaction Methods 0.000 abstract 1
229910052791 calcium Inorganic materials 0.000 abstract 1
239000011575 calcium Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000000148 hypercalcaemia Effects 0.000 abstract 1
208000030915 hypercalcemia disease Diseases 0.000 abstract 1
230000000968 intestinal effect Effects 0.000 abstract 1
230000009103 reabsorption Effects 0.000 abstract 1
230000001988 toxicity Effects 0.000 abstract 1
231100000419 toxicity Toxicity 0.000 abstract 1
239000011647 vitamin D3 Substances 0.000 abstract 1
229940021056 vitamin d3 Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Obesity (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pretreatment Of Seeds And Plants (AREA)
Processing Of Solid Wastes (AREA)
Crystals, And After-Treatments Of Crystals (AREA)
Disintegrating Or Milling (AREA)
Fertilizers (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT89910341T 1988-08-02 1989-08-02 Verfahren zur behandlung und vorbeugung des verlustes von knochenmasse. ATE114471T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US22737188A	1988-08-02	1988-08-02

Publications (1)

Publication Number	Publication Date
ATE114471T1 true ATE114471T1 (de)	1994-12-15

Family

ID=22852835

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT89910341T ATE114471T1 (de)	1988-08-02	1989-08-02	Verfahren zur behandlung und vorbeugung des verlustes von knochenmasse.

Country Status (11)

Country	Link
EP (1)	EP0381750B1 (de)
JP (1)	JP3030854B2 (de)
AT (1)	ATE114471T1 (de)
AU (1)	AU634490B2 (de)
CA (1)	CA1341408C (de)
DE (1)	DE68919673T2 (de)
GB (1)	GB2231794B (de)
MX (1)	MX9203760A (de)
NL (1)	NL8920901A (de)
SE (1)	SE9001308D0 (de)
WO (1)	WO1990001321A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7056882B2 (en)	1991-03-11	2006-06-06	Curis, Inc.	Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
JPH0753384A (ja) *	1993-07-13	1995-02-28	Wisconsin Alumni Res Found	２４−エピ−１α−ヒドロキシビタミンＤ２を含んでなる骨粗鬆症治療剤
US5763429A (en) *	1993-09-10	1998-06-09	Bone Care International, Inc.	Method of treating prostatic diseases using active vitamin D analogues
IL115241A (en) *	1994-09-26	2000-08-31	American Cyanamid Co	Calcium dietary supplement
US20020183288A1 (en) *	1995-04-03	2002-12-05	Bone Care International, Inc.	Method for treating and preventing hyperparathyroidism
US6376479B1 (en)	1995-04-03	2002-04-23	Bone Care International, Inc.	Method for treating and preventing hyperparathyroidism
US6096876A (en) *	1997-08-06	2000-08-01	Shriners Hospitals For Children	1-α-hydroxylase materials and methods
CA2556405A1 (en) *	2004-02-18	2005-08-25	Mercian Corporation	Method of preventing, medicating and/or treating hypocalcaemia of domestic mammal
US7094775B2 (en)	2004-06-30	2006-08-22	Bone Care International, Llc	Method of treating breast cancer using a combination of vitamin D analogues and other agents
CN101668532B (zh) *	2007-04-25	2014-08-20	赛特克罗公司	治疗维生素d不足和缺乏、继发性甲状旁腺功能亢进症和维生素d-响应疾病的组合物及其相应的制药用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4225596A (en)	1978-10-13	1980-09-30	Wisconsin Alumni Research Foundation	Method for treating calcium imbalance and improving calcium absorption in mammals
DE3490215C2 (de) *	1983-05-09	1991-07-25	Wisconsin Alumni Res Found
US4588716A (en) *	1984-05-04	1986-05-13	Wisconsin Alumni Research Foundation	Method for treating metabolic bone disease in mammals
IL78342A (en) *	1985-04-04	1991-06-10	Gen Hospital Corp	Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof
US5104864A (en) *	1988-08-02	1992-04-14	Bone Care International, Inc.	Method for treating and preventing loss of bone mass

1988
- 1988-11-15 CA CA000583162A patent/CA1341408C/en not_active Expired - Fee Related
1989
- 1989-08-02 AU AU42203/89A patent/AU634490B2/en not_active Ceased
- 1989-08-02 WO PCT/US1989/003341 patent/WO1990001321A2/en not_active Ceased
- 1989-08-02 AT AT89910341T patent/ATE114471T1/de not_active IP Right Cessation
- 1989-08-02 NL NL8920901A patent/NL8920901A/nl not_active Application Discontinuation
- 1989-08-02 DE DE68919673T patent/DE68919673T2/de not_active Expired - Fee Related
- 1989-08-02 JP JP1509666A patent/JP3030854B2/ja not_active Expired - Fee Related
- 1989-08-02 EP EP89910341A patent/EP0381750B1/de not_active Expired - Lifetime
1990
- 1990-03-28 GB GB9006990A patent/GB2231794B/en not_active Expired - Fee Related
- 1990-04-10 SE SE9001308A patent/SE9001308D0/xx not_active Application Discontinuation
1992
- 1992-06-29 MX MX9203760A patent/MX9203760A/es unknown

Also Published As

Publication number	Publication date
JP3030854B2 (ja)	2000-04-10
GB2231794B (en)	1992-01-15
NL8920901A (nl)	1990-07-02
SE9001308L (sv)	1990-04-10
SE9001308D0 (sv)	1990-04-10
MX9203760A (es)	1992-09-01
WO1990001321A2 (en)	1990-02-22
EP0381750A1 (de)	1990-08-16
GB9006990D0 (en)	1990-08-29
AU634490B2 (en)	1993-02-25
JPH03501388A (ja)	1991-03-28
DE68919673D1 (de)	1995-01-12
EP0381750B1 (de)	1994-11-30
AU4220389A (en)	1990-03-05
DE68919673T2 (de)	1995-06-01
GB2231794A (en)	1990-11-28
CA1341408C (en)	2002-12-10
WO1990001321A3 (en)	1990-05-17

Similar Documents

Publication	Publication Date	Title
RU94027680A (ru)	1996-11-10	Паращитовидный гормон и ралоксифон для увеличения массы кости, фармацевтический состав и способ увеличения костной массы
GEP20032925B (en)	2003-03-25	Benzothiepines Having Activity As Inhibitors of Ileal Bile Acid Transport and Taurocholate Uptake
RU92004521A (ru)	1995-03-10	Применение бисфосфонатов и экстракта паращитовидных желез для лечения остеопороза и набор для лечения
MY111188A (en)	1999-09-30	Improvements in or relating to benzothiophenes.
MY117892A (en)	2004-08-30	Therapeutic compounds
EP0401903A3 (de)	1992-04-29	Verwendung von Vanilloiden zur Behandlung von Erkrankungen der Atemwege
RU93054017A (ru)	1997-01-27	Способ лечения остеопороза, композиция для лечения остеопороза, применение активно действующего на кости фосфоната и эстрогенного гормона для лечения остеопороза
UA35567C2 (uk)	2001-04-16	Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
DE69501419D1 (de)	1998-02-19	Pharmazeutische Zusammensetzung zur Behandlung von Osteoporose enthaltend Xanthohumol
ATE202709T1 (de)	2001-07-15	Zusammensetzungen die g-csf und ein tnf- bindungsprotein enthalten
ATE114471T1 (de)	1994-12-15	Verfahren zur behandlung und vorbeugung des verlustes von knochenmasse.
SE7612534L (sv)	1977-06-02	Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning
KR880003620A (ko)	1988-05-28	치료용 합성물 및 치료법(Therapeutic Composition and Method)
RU2003136733A (ru)	2005-05-20	Пероральное введение паратиреоидного гормона и кальцитонина
KR890003390A (ko)	1989-04-14	골다공증 및 관련된 장해의 치료방법
AP9801286A0 (en)	1998-09-30	Therapeutic compounds.
BR0212249A (pt)	2004-10-05	Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto
DE02748548T1 (de)	2004-11-11	Calcium-l-threonat zur prävention oder behandlung von knochenfrakturen
ATE193206T1 (de)	2000-06-15	Zusammensetzung zur behandlung oder vorbeugung von herpes
RU93053982A (ru)	1996-11-10	Мазь для лечения открытых ран
KR930021178A (ko)	1993-11-22	뼈 형성을 자극하는 약제
DE69424747D1 (de)	2000-07-06	Pharmazeutische Zusammensetzung zur Vorbeugung oder Behandlung von Knochenbrüchen
DE69528068D1 (de)	2002-10-10	Conagenine zur prävention und behandlung von diarrhöe
ES2123666T3 (es)	1999-01-16	Aplicacion de estriol para la preparacion de un sistema terapeutico transdermico para tratar la osteoporosis climaterica.
KR980700083A (ko)	1998-03-30	골다공증 치료 주기용 키트(KIT for Osteoporosis Treatment Cycle)

Legal Events

Date	Code	Title	Description
1995-05-15	UEP	Publication of translation of european patent specification
2003-05-15	REN	Ceased due to non-payment of the annual fee